Seducing stocks: Vivos Therapeutics, Inc. (VVOS -4.87%), Dare Bioscience, Inc. (DARE -1.18%)

VVOS has seen its SMA50 which is now -19.51%. In looking the SMA 200 we see that the stock has seen a -42.81%.

DARE has seen its SMA50 which is now -14.42%. In looking the SMA 200 we see that the stock has seen a -25.00%.

On 08-15-2k23 (Tuesday), Shares of Vivos Therapeutics, Inc. (NASDAQ:VVOS) encountered a difference of -4.87% after which it shut the day’ session at $0.33. The volume added 430,160 shares which compares with the average volume of 1.56M shares.

Vivos Therapeutics, Inc., a USA based Company, belongs to Medical Devices sector industry. Shares of Vivos Therapeutics, Inc. was among the active stocks of the last exchanging sessions.


The stock value instability stayed at 14.66% in recent month and ranges at 17.58% for the week. The Average True Range (ATR) is also a measure of volatility is presently sitting at 0.06. The firm demonstrates the market capitalization of $9.61M.

Important Results:

Vivos Therapeutics, Inc. has P/S value of 0.59 while its P/B esteem remains at 1.17. Likewise, the company has Return on Assets of -70.40%, Return on Equity of -221.60% and Return on Investment of -494.70%.

The company demonstrates Gross Margin and Operating Margin of 60.40% and 0 respectively.

Forward P/E of Vivos Therapeutics, Inc. is remaining at 0. Forward P/E is a measure of the price-to-earnings ratio using forecasted earnings for the P/E calculation for the next fiscal year.

Technical Analysis of Vivos Therapeutics, Inc. VVOS:

The stock price moved with change of 41.73% to its 50 Day low spot and changed -41.78% contrasting with its 50 Day high point. VVOS stock is as of now appearing down return of -18.38% all through a week ago and saw bearish return of 4.35% in one month span. The execution of company -1.09% in three months and -64.72% throughout the previous a half year exchanging period.

Tracking the closing price and 52-week high, the current price movement shows that the stock price positioned negative when compared against the 52-week high. As close of recent trade, stock represents -88.98%move from 52-week high. Tracing the 52-week low position of the stock, we noted that the closing price represents a 41.73% higher distance from that low value. Technical analysts compare a stock’s current trading price to its 52-week range to get a broad sense of how the stock is doing, as well as how much the stock’s price has fluctuated. This information may indicate the potential future range of the stock and how volatile the shares are.

Dare Bioscience, Inc. (NASDAQ:DARE)’s Analysis & Performances to Discover

Dare Bioscience, Inc., belongs to Healthcare sector and Biotechnology industry. The company’s total Outstanding Shares of 85.52M. DARE flaunted -1.18% to reach at $0.73 during previous trading session.

The company has experienced volume of 374,589 shares while on average the company has a capacity of trading 298.01K share.

Observing the Technical Indicators:

Dare Bioscience, Inc. institutional ownership is held at 9.30% while insider ownership was 1.93%. As of now, DARE has a P/S, P/E and P/B values of 5.98, 0 and 12.25 respectively. Its P/Cash is valued at 3.02.

The Company’s net profit margin for the 12 months at 0. Comparatively, the gazes have a Gross margin 0.

Profitability ratios:

Looking into the profitability ratios of DARE stock, an investor will find its ROE, ROA, ROI standing at -164.00%, -70.40% and -282.80%, respectively.

Reading RSI Indicator

Dare Bioscience, Inc. (DARE) attained alert from day Traders as RSI reading reached at 39.69. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements.

Earnings per Share Details of Dare Bioscience, Inc.:

The EPS of DARE is strolling at -0.37, measuring its EPS growth this year at 42.20%. As a result, the company has an EPS growth of 23.10% for the approaching year.

What Does the Payout Ratio Tell You?

The payout ratio is a key financial metric used to determine the sustainability of a company’s dividend payments. It is the amount of dividends paid to shareholders relative to the total net income of a company.

Formula for the Payout Ratio Is

“Payout Ratio = Dividends / Earnings”

Is It Overvalued? Look at the Payout Ratio of VVOS, DARE

The payout ratio shows the proportion of earnings paid out as dividends to shareholders, typically expressed as a percentage of the company’s earnings. The payout ratio can also be expressed as dividends paid out as a proportion of cash flow. The payout ratio is also known as the dividend payout ratio. VVOS has a Payout Ratio of 0 and DARE has a Payout Ratio of 0.

About Jake Charles

This is Jake Charles, a Senior News Writer for “Stocks Equity”. I covers “Active Stocks” sector and writes about trending Active Hot companies from an exclusive and “out of the box” perspective. I worked independently as a self motivator and with the financial institute as financial adviser to invest in the Active sector for over 9 years in the developing countries by introducing new phases and ways to improve in this sector. I like to travel all over the globe to get new experience and provide by best services to the companies. As an advisor I like to work with new people to share and explore new ideas keeping in view minimizing the operating cost and giving the best final product through new technology and minimizing the time of development.

View all posts by Jake Charles →

Leave a Reply

Your email address will not be published. Required fields are marked *